Lergotrile
Lergotrile is a medication that belongs to the class of drugs known as ergot alkaloids. It was developed by Sandoz, a Swiss pharmaceutical company, and is used in the treatment of Parkinson's disease and hyperprolactinemia.
Pharmacology[edit]
Lergotrile acts as an agonist at dopamine receptors, specifically the D2 subtype. This action is responsible for its therapeutic effects in Parkinson's disease and hyperprolactinemia. In addition to its dopaminergic activity, lergotrile also has serotonergic and adrenergic effects.
Clinical Use[edit]
Lergotrile is used in the treatment of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra. By acting as a dopamine receptor agonist, lergotrile can help to alleviate the motor symptoms of this disease.
In addition to its use in Parkinson's disease, lergotrile is also used to treat hyperprolactinemia, a condition characterized by abnormally high levels of prolactin in the blood. Lergotrile's dopaminergic activity can help to reduce prolactin levels and alleviate the symptoms of this condition.
Side Effects[edit]
Like all medications, lergotrile can cause side effects. These may include nausea, vomiting, dizziness, and orthostatic hypotension. In rare cases, lergotrile can cause pulmonary fibrosis, a serious lung disease.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
References[edit]
External Links[edit]
- Lergotrile on Drugs.com
- Lergotrile on PubChem
| Drugs used for Parkinson's disease | ||||||||
|---|---|---|---|---|---|---|---|---|
This Parkinson's disease related article is a stub.
|
| Drugs used for Hyperprolactinemia | ||||||||
|---|---|---|---|---|---|---|---|---|
This hyperprolactinemia related article is a stub.
|
-
Lergotrile
